Abstract
Revision knee arthroplasty is a major undertaking for most patients, particularly septic revisions which carry a high morbidity and mortality. In a large cohort of rTKA cases at our tertiary centre, the 10-year survivorship of septic revisions was 68.7 and 80.2% for aseptic revisions. These findings have important practical implications as these outcomes are comparable to those that we see in some cancer patients; the risk of mortality following septic rTKA is higher than that of some of the most common cancers. This reality should be highlighted in candid discussions when counselling patients not only at time of revision surgery, when patients have little choice when infection has already developed, but more importantly at time of primary TKA, particularly for those patients who are at higher risk for developing periprosthetic joint infection. This chapter focuses on long-term mortality in revision knee patients, particularly focusing on septic versus aseptic revisions.
You can die of the cure before you die of the illness.
Michael Landon.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harris IA, et al. How does mortality risk change over time after hip and knee arthroplasty? Clin Orthop Relat Res. 2019;477(6):1414–21.
Hamilton DF, et al. Dealing with the predicted increase in demand for revision total knee arthroplasty: challenges, risks and opportunities. Bone Joint J. 2015;97-b(6):723–8.
Geary MB, et al. Why do revision total knee arthroplasties fail? A single-center review of 1632 revision total knees comparing historic and modern cohorts. J Arthroplasty. 2020.
Singh JA, et al. Rates of total joint replacement in the United States: Future projections to 2020–2040 using the national inpatient sample. J Rheumatol. 2019;46(9):1134–40.
17th Annual Report of the National Joint Registry for England, Wales, Northern Ireland, the Isle of Man and the States of Guernsey. https://reports.njrcentre.org.uk/Portals/0/PDFdownloads/NJR%2017th%20Annual%20Report%202020.pdf. Accessed 23 Oct 2020.
Greidanus NV, et al. Quality of life outcomes in revision versus primary total knee arthroplasty. J Arthroplasty. 2011;26(4):615–20.
Blom AW, et al. Infection after total knee arthroplasty. J Bone Joint Surg Br. 2004;86(5):688–91.
Huotari K, Peltola M, Jämsen E. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015;86(3):321–5.
Kurtz SM, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012;27(8 Suppl):61-5.e1.
Meyer E, et al. Impact of department volume on surgical site infections following arthroscopy, knee replacement or hip replacement. BMJ Qual Saf. 2011;20(12):1069–74.
Boddapati V, et al. Revision total knee arthroplasty for periprosthetic joint infection is associated with increased postoperative morbidity and mortality relative to noninfectious revisions. J Arthroplasty. 2018;33(2):521–6.
Lum ZC, et al. Mortality during total knee periprosthetic joint infection. J Arthroplasty. 2018;33(12):3783–8.
Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35–9.
Matar HE, et al. Septic revision total knee arthroplasty is associated with significantly higher mortality than aseptic revisions: Long-term single-center study (1254 Patients). J Arthroplasty. 2021.
Bayliss LE, et al. The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet. 2017;389(10077):1424–30.
Jones MD, et al. Early death following revision total knee arthroplasty. J Orthop. 2020;19:114–7.
Memtsoudis SG, et al. Risk factors for perioperative mortality after lower extremity arthroplasty: A population-based study of 6,901,324 patient discharges. J Arthroplasty. 2010;25(1):19–26.
Traven SA, et al. Frailty predicts medical complications, length of stay, readmission, and mortality in revision hip and knee arthroplasty. J Arthroplasty. 2019;34(7):1412–6.
Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–4.
Leone JM, Hanssen AD. Management of infection at the site of a total knee arthroplasty. Instr Course Lect. 2006;55:449–61.
Parvizi J, et al. The 2018 definition of periprosthetic hip and knee infection: An evidence-based and validated criteria. J Arthroplasty. 2018;33(5):1309-1314.e2.
Freeman MA, et al. The management of infected total knee replacements. J Bone Joint Surg Br. 1985;67(5):764–8.
Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status-historical perspectives and modern developments. Anaesthesia. 2019;74(3):373–9.
Choi HR, Bedair H. Mortality following revision total knee arthroplasty: A matched cohort study of septic versus aseptic revisions. J Arthroplasty. 2014;29(6):1216–8.
Yao JJ, et al. Long-term mortality trends after revision total knee arthroplasty. J Arthroplasty. 2019;34(3):542–8.
Zmistowski B, et al. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am. 2013;95(24):2177–84.
Cancer Statistics for the UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk. Accessed 2 Aug 2020.
Alamanda VK, Springer BD. The prevention of infection: 12 modifiable risk factors. Bone Joint J. 2019;101-b(1_Supple_A):3–9.
Lenguerrand E, et al. Risk factors associated with revision for prosthetic joint infection following knee replacement: An observational cohort study from England and Wales. Lancet Infect Dis. 2019;19(6):589–600.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Matar, H.E., Bloch, .V., Cameron, H.U., James, P.J. (2021). Mortality in Revision Knee Arthroplasty. In: Revision Total Knee Arthroplasty. Springer, Cham. https://doi.org/10.1007/978-3-030-81285-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-81285-0_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81284-3
Online ISBN: 978-3-030-81285-0
eBook Packages: MedicineMedicine (R0)